Grupo en Xenética e Epidemioloxía do Cancro
RIKEN Advanced Science Institute
Kōbe, JapónPublicacións en colaboración con investigadores/as de RIKEN Advanced Science Institute (6)
2021
-
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0)
Nature Genetics
-
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Nature Genetics, Vol. 53, Núm. 1, pp. 65-75
2019
-
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
Nature Communications, Vol. 10, Núm. 1
2016
-
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics
PLoS ONE, Vol. 11, Núm. 9
2009
-
Testing the druggable endothelial differentiation gene 2 knee osteoarthritis genetic factor for replication in a wide range of sample collections
Annals of the Rheumatic Diseases, Vol. 68, Núm. 6, pp. 1017-1021